Michigan Medicine University of Michigan Int. Medicine Oncology — Ann Arbor, Michigan

Michigan Medicine University of Michigan Int. Medicine Oncology is a clinical research site located in Ann Arbor, Michigan, United States 48109 5271.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Michigan Medicine University of Michigan Int. Medicine Oncology has participated in 2 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ann Arbor

Browse all research sites in Michigan · View every site in Ann Arbor

• University of Michigan A. Alfred Taubman Health Care Center
• University of Michigan Comprehensive Cancer Center /ID# 207177
• CFF Pediatric Program University of Michigan
• University of Michigan-Ann Arbor, Cystic Fibrosis Center
• C S Mott Children's Hospital
• Lieutenant Colonel Charles S. Kettles VA Medical Center - Oncology
• University of Michigan Health System Allergy Specialty Clinic
• MedSport - University of Michigan
• University of Michigan Health System Clinical Trials Office
• University of Michigan Ann Arbor
• University of Michigan School of Public Health
• VA Ann Arbor Health Care System

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan Medicine University of Michigan Int. Medicine Oncology?

Michigan Medicine University of Michigan Int. Medicine Oncology has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan Medicine University of Michigan Int. Medicine Oncology conducted?

Michigan Medicine University of Michigan Int. Medicine Oncology has 2 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation.

Is Michigan Medicine University of Michigan Int. Medicine Oncology accredited by Crixeo Clinical Trials?

Michigan Medicine University of Michigan Int. Medicine Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michigan Medicine University of Michigan Int. Medicine Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.